Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioStocks Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::112872946.png) Bio Stocks™ [@BioStocks](/creator/twitter/BioStocks) on x 68.6K followers
Created: 2025-07-10 11:39:03 UTC

$ABBV and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody.

IGI will receive an upfront payment of $700M + up to $1.25B in milestone payments.




XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943273759906902309/c:line.svg)

**Related Topics**
[$125b](/topic/$125b)
[$700m](/topic/$700m)
[stocks](/topic/stocks)
[$abbv](/topic/$abbv)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/BioStocks/status/1943273759906902309)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BioStocks Avatar Bio Stocks™ @BioStocks on x 68.6K followers Created: 2025-07-10 11:39:03 UTC

$ABBV and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody.

IGI will receive an upfront payment of $700M + up to $1.25B in milestone payments.

XXXXXX engagements

Engagements Line Chart

Related Topics $125b $700m stocks $abbv stocks healthcare

Post Link

post/tweet::1943273759906902309
/post/tweet::1943273759906902309